RallyRaider
Posted - 7 months ago
$KDNY $VERA will get FDA approval in IGAN, i believe its taken out after that. After i got out around 31, ill buy some shares today. Alwas follow the money.
RallyRaider
Posted - 8 months ago
$KDNY $VERA by the looks of it, VERA is next...
fin_researcher
Posted - 10 months ago
$KDNY In May 2023, Muddy Waters accused Chinook and AbbVie of manipulating trial results for lead product candidate, Atrasentan. On it, $KDNY fell 7%, losing $100M+ shareholder value. Investors may have reasons to suspect Chinook of unlawful biz practices, which consequently led to their losses: https://11thestate.com/cases/chinook-investor-case
Stan_Vick
Posted - 12/30/23
~ In May 2023, Muddy Waters accused #
Chinook and AbbVie of manipulating trial results for lead product candidate.
~ $KDNY fell 7%, losing $100M+ shareholder value.
~ Investors may suspect $KDNY of unlawful biz practices, which led to their losses => https://11thestate.com/cases/chinook-investor-case
Uncle_Sammy_Trades
Posted - 11/30/23
$KDNY how is the chart here the same every day? This is a scam.
stockilluminati
Posted - 1 year ago
$KDNY https://www.stockilluminati.com/kdny/filings.php - Chinook Therapeutics, Inc. - Common Stock files form 15-12G today, check out the details.
Quantisnow
Posted - 1 year ago
$KDNY 📜 SEC Form 15-12G filed by Chinook Therapeutics Inc.
https://quantisnow.com/i/4921829?utm_source=stocktwits
45 seconds delayed.
tickeron
Posted - 1 year ago
Chinook Therapeutics to report earnings on August 21, 2023. Earnings per share (EPS) estimate: $-0.90 $KDNY https://srnk.us/go/4838684
stockilluminati
Posted - 1 year ago
$KDNY https://www.stockilluminati.com/kdny/filings.php - Chinook Therapeutics, Inc. - Common Stock files form EFFECT today, check out the details.
Quantisnow
Posted - 1 year ago
$KDNY 📜 SEC Form EFFECT filed by Chinook Therapeutics Inc.
https://quantisnow.com/i/4909081?utm_source=stocktwits
45 seconds delayed.
MGCapManagement
Posted - 1 year ago
$KDNY anyone know what happens to my call exp 8.18? How will they expire? Do I get paid? I wrote to chinook and they haven't responded.
Twit_Rip
Posted - 1 year ago
$KDNY i sold this for somewhere between 19-22$ i hate myself right now. I only had 5 shares kicking around. Ill make 200$ off this merger. :( … i dont know what i was thinking i always believed in this stock… some lucky people out there getting paid $$$
tickeron
Posted - 1 year ago
Chinook Therapeutics to report earnings on August 14, 2023. Earnings per share (EPS) estimate: $-0.85 $KDNY https://srnk.us/go/4829907
Kewgardens
Posted - 1 year ago
$KDNY Had some short $40 $KDNY calls called away right before the deal closed. So as of today, I am short about 1500 shares at ~$40.73 (strike plus premium). I know that my account will be debited $40 per share because of the $40 per cash offer. But what happens to the CVRs? Will a CVR security be issued? Will it trade on an exchange? I will be short that security and will be looking to close out my position. How do thinks proceed from here?
Last10K
Posted - 1 year ago
$KDNY just filed with the SEC a Ending Agreement, a Change in Assets, a Listing Status, a Security Holders Change, a Change in Control, a Event for Officers, a Bylaw Change and a Financial Exhibit https://last10k.com/sec-filings/KDNY/0001193125-23-210803.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=KDNY
stockilluminati
Posted - 1 year ago
$KDNY https://www.stockilluminati.com/kdny/filings.php - Chinook Therapeutics, Inc. - Common Stock files form SC 13D today, check out the details.
SkiesOfBlue
Posted - 1 year ago
@BeaconABB Short term damage from capital raise to complete Ph3 activities. But they know owning a big winner for long term, with future partnerships or even potential buyout. I own $KDNY and got 6x gain from recent buyout by $NVS. Just my opinion and not financial advice. Do your own DD and place your bet GL
stockilluminati
Posted - 1 year ago
$KDNY https://www.stockilluminati.com/kdny/filings.php - Chinook Therapeutics, Inc. - Common Stock files form POSASR today, check out the details.
